Balance Sheet Details - Schedule of Accrued Expenses (Details) - USD ($) $ in Thousands		Dec. 31, 2022	Dec. 31, 2021	[1]
Accrued Liabilities, Current [Abstract]
Clinical Studies		$ 1,518	$ 453
Other research and development	[2]	12,446	4,676
Other accrued expenses		1,411	3,658
Total		$ 15,375	$ 8,787

[1] The breakout and categorizations of the 2021 total accrued expenses have been updated to conform to the 2022 presentation.

[2] Includes $5.0 million and $0 of accrued manufacturing rights as of December 31, 2022 and 2021, respectively. See Note 6, "Commitments and Contingencies, Sutro Option Agreement," for further details.